Health

RaySecur to Be Featured Supporter at 2025 Rx and Illicit Drug Summit
Wayfinder Biosciences and Daiichi Sankyo collaborate to develop novel RNA-targeting therapies for neurodegenerative disease
Crunch Fitness Continues Expansion In Florida With Acquisition Of Nine 24 Hour Fitness Gyms
Pathways LA Celebrates Early Education Success with Seeds of Hope Fundraiser at the Iconic Grammy Museum
Future Method Celebrates National Anal Sex Day By Unveiling the Anal Douche Kit: A New Standard in Confidence, Comfort, and Cleanliness
True North Oral Surgery & Implants Announces Launch of New Website
AMSURG Continues Growth With Acquisition of Pinnacle Surgery Center
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics
Five to Flow® Launches Discover Flow® eLearning to Tackle Burnout, Unhealthy Stress, and Cognitive Overload
Vascarta commences Proof of Concept Phase 1 clinical study of VAS-101 in sickle cell disease in the United States
Expert Vein Care Comes to Maple Lawn with Dr. Lisa Alford, Dr. Kamran Saraf, and the Vein Treatment Clinic
ActiveProtective Receives FDA Marketing Authorization for the Tango Belt, a Breakthrough-Designated Wearable Device for the Prevention of Fall-Induced Hip Fractures in Older Adults
Instylla Announces the Appointment of Daniel Davis to Board of Directors
Medscape's 2025 Physician Compensation Report: Small Pay Gains, Increasing Financial Pressures
RevitaLash® Cosmetics annonce son objectif de 10 millions de dollars pour soutenir les initiatives de lutte contre le cancer du sein.
RevitaLash® Cosmetics Announces Road to $10 Million Goal in Support of Breast Cancer Initiatives
RevitaLash® Cosmetics kündigt den Weg zum 10-Millionen-Dollar-Ziel zur Unterstützung von Brustkrebsinitiativen an
MetaVia Announces Positive Top-Line Data From the 4-Week Phase 1 MAD Trial of DA-1726, a Novel 3:1 Ratio GLP-1 Glucagon Dual Receptor Agonist to Treat Obesity, Showing Compelling Weight Loss and Safety Effects With Potential Best-In-Class Glucose Control (GLP-1R), Waist Reduction (GCGR), and Tolerability
ThirtyFiveBio Closes Bridge Round of Financing Highlighted by Strategic New Investment from AbbVie Ventures
Revelstoke Capital Partners Makes Significant Investment in AOM Infusion